AI-SARs may reduce depressive symptoms and agitation among older adults with ADRD. However, evidence for other outcomes remains inconclusive. Future research should focus on large-scale trials with standardized outcomes and explore the role of AI-SARs in supporting caregivers.
Chen et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: